Aesthetics-focused healthcare credit card for elective treatments
Alphaeon Credit is the most aesthetics-native financing option with competitive merchant economics, but its deferred-interest model and strongly negative consumer sentiment make patient disclosure and transparency the deciding factors.
Alphaeon Credit is a healthcare credit card designed specifically for the aesthetics market, issued by Comenity Capital Bank (Bread Financial) and marketed under the banner "Helping Doctors Help More Patients." Unlike horizontal point-of-sale lenders, it is purpose-built for cosmetic, dermatology, plastic surgery, and med-spa practices, with more than 12,500 provider locations in its network. As a revolving credit line of up to $25,000 (some sources cite $35,000), it lets patients finance elective treatments and apply special financing to purchases of $250 or more, with a soft pull available for pre-qualification.
Because Alphaeon is a bank-issued card, the practice is paid on a non-recourse basis up front, minus a tiered merchant fee of roughly 3.5% for clinics under $500K in annual volume, 3.3% from $500K to $1M, and 3.15% above $1M, with deferred-interest plans costing more. The defining concern is the consumer side: alongside a standard purchase APR around 32.99% and reduced-APR promotions of 14.99% to 17.99%, Alphaeon leans heavily on deferred-interest "no interest if paid in full" plans of 6 to 36 months. If a patient does not pay the balance in full by the deadline, interest is charged retroactively from the original purchase date, a structure that is the dominant driver of independent complaints and one that buyers should weigh carefully against its strong aesthetics fit.
Ideal customer
Aesthetic, cosmetic, dermatology, and plastic surgery practices that want an aesthetics-native credit-card financing program and competitive merchant economics, and are prepared to manage the patient-disclosure risk of deferred-interest plans.
Alphaeon Credit is the most aesthetics-native option in this category. Where most patient-financing players are horizontal lenders that happen to serve med spas, Alphaeon is a healthcare credit card built specifically for cosmetic, dermatology, plastic surgery, and aesthetic practices, with the tagline "Helping Doctors Help More Patients" and more than 12,500 provider locations in its network. Issued by Comenity Capital Bank (Bread Financial), it is a revolving line of up to $25,000 (some sources cite $35,000) that applies special financing to purchases of $250 or more, with a soft pull available for pre-qualification.
For the practice, the economics are reasonable: because it is a bank-issued card, payouts are non-recourse and up front, minus a tiered merchant fee of roughly 3.5% under $500K in annual volume, 3.3% from $500K to $1M, and 3.15% above $1M. That places its merchant cost in line with, or below, several competitors.
The concerns are significant and concentrate on the patient side. Alphaeon leans heavily on deferred-interest "no interest if paid in full" plans of 6 to 36 months. If the patient does not clear the balance by the deadline, interest is charged retroactively from the original purchase date, and the standard purchase APR is around 32.99%. This structure is the single largest driver of complaints, and it is a model we penalize on value and transparency grounds because patients frequently misunderstand the retroactive-interest trigger.
The independent sentiment bears this out. The only usable third-party numeric signal is PissedConsumer at roughly 1.2 out of 5 across about 104 reviews — a strongly negative score centered on deferred-interest surprises and service issues. Alphaeon is not BBB-accredited and not rated, and its Trustpilot presence is effectively empty (only a couple of reviews, not usable). We deliberately do not credit Alphaeon's self-reported 4.8 figure, as it is not an independent source. There are also no confirmed med-spa practice-management integrations.
Choose Alphaeon Credit if aesthetics specialization and competitive merchant economics are your priority and you have the front-desk discipline to clearly disclose deferred-interest terms to patients. The strong aesthetics fit and decent merchant pricing are real, but the deferred-interest model and severe consumer-complaint pattern are equally real, and they fall on your patients. If patient experience and transparent, plain-vanilla installment terms matter most, weigh Alphaeon against true installment lenders before committing.
By Med Spa Vendor Hub Editorial Team. Last reviewed July 28, 2026. Independent editorial review — how we score.
Alphaeon does publish a tiered revolving practice fee — 3.5% / 3.3% / 3.15% by annual financing volume — but only on co-branded dental and vision buying-group pages, only for the revolving plan, and only on charges under $250. Those pages frame the rates as negotiated for members in good standing, so they may not be universal. Fees for the deferred-interest and promotional plans a med spa typically runs are not published. Verified 28 July 2026.
Revolving practice fee, under $500K/yr
3.5%
per transaction
Revolving plan only, and only on charges under $250. Published on partner buying-group pages.
Revolving practice fee, $500K–$1M/yr
3.3%
per transaction
Same scope limits; discounted on projected annual financing volume.
Revolving practice fee, over $1M/yr
3.15%
per transaction
Same scope limits.
Promotional-plan practice fee
Not published
per transaction
Fees for deferred-interest and promotional plans — the plans med spas most often run — are not published anywhere.
Pricing is researched from public sources and verified periodically; confirm current rates with the vendor.
Independent ratings from third-party review platforms, cited with sources. These are not our score.
A vendor-neutral guide to choosing patient financing for a med spa—covering why financing drives conversion, the six provider models, the deferred-interest trap, merchant economics, and how to match a provider to your patients.
Patient financing has no subscription - the practice pays a merchant discount fee (a % of each financed sale) and the patient pays APR or deferred interest. Here's a transparent 2026 breakdown of real merchant fees and patient rates by lender.
Patient FinancingAffirm is a large general-purpose buy-now-pay-later and installment lender that pays merchants up front and assumes default risk, used by some med spas through Zenoti and Stripe-based POS rather than built for aesthetics.
Patient FinancingAfterpay, owned by Block (Square), is a mainstream buy-now-pay-later provider offering interest-free Pay-in-4 on smaller purchases. Some beauty businesses and med spas use it for retail and lower-ticket services, but it is not a healthcare-built financing product for higher-ticket aesthetic procedures.
Patient FinancingCareCredit is the incumbent revolving healthcare credit card from Synchrony Bank, accepted at 250,000+ provider locations and the exclusive financing partner of AmSpa — but its deferred-interest model and poor consumer-satisfaction ratings warrant caution.
